The Spice That Might Turn on Your Cancer's Growth Signals
Luteolin, a compound found in lemon peel and moringa, activates toll-like receptor signaling [5, 11]—the same inflammatory pathway that trastuzumab, a common breast cancer drug, often works to quiet. This surprising finding from preclinical research highlights why your diet matters just as much as your prescription.
Key Findings
- Onion's delphinidin inhibits focal adhesion and MAPK signaling [3, 4]—two key processes cancer cells use to spread.
- Lemon peel and moringa contain luteolin, which activates steroid hormone biosynthesis and toll-like receptor signaling [5, 6, 11, 12]—pathways that could potentially influence cancer growth.
- Blackberry's ellagic acid activates the PI3K-Akt signaling pathway (a major driver of cell growth and survival) [9].
Why Nutrition Matters with Trastuzumab
Your treatment, trastuzumab (often known as Herceptin), is a targeted therapy. It works by attaching to the HER2 protein on cancer cells, blocking signals that tell them to grow and division. It also flags the cells for your immune system to destroy. Since trastuzumab works by blocking HER2-mediated activation of PI3K-Akt, foods containing compounds that also activate this pathway could theoretically work against the drug.
Breast cancer is driven by complex networks of signals. The most common genetic change found in these cancers is a mutation in the TP53 gene, a crucial tumor suppressor that normally acts as a "stop sign" for faulty cell division. When TP53 is broken, cancer cells can ignore signals to stop growing or to die.
This is where your diet plays a role. The compounds in food can interact with these very same cellular pathways. Some can support your treatment by reducing inflammation or making it harder for cancer to spread. Others, however, might accidentally activate the same growth signals your medication is trying to shut down. The goal is to choose foods that work with your therapy, not against it.
Molecular Pathway
Foods That May Work With Your Treatment
Onion: potentially blocking cancer spread
Onions contain a compound called delphinidin. Laboratory studies show it can inhibit focal adhesion [3]. However, these findings are from studies in colorectal cancer and osteosarcoma, not breast cancer specifically. It also inhibits the MAPK signaling pathway [4], another major chain of commands that cancer cells use to proliferate. Adding raw or lightly cooked onions to salads and meals is a simple strategy.
Molecular Pathway
Foods to Approach with Caution
The PI3K-Akt Activation Concern
One of the most important pathways in cancer is PI3K-Akt. It's a primary growth signal, and many treatments aim to block it. Ellagic acid, found in blackberries, has been shown to activate the PI3K-Akt signaling pathway [9]. However, this finding comes from studies in depression models, not cancer research. In the context of cancer, activating this growth pathway is a potential concern.
The Hormone and Inflammation Signal
Luteolin is found in both lemon peel and moringa. Research indicates it activates toll-like receptor signaling [5, 11]—a pathway that kicks the immune system into gear and can promote inflammation. However, these studies were conducted in precocious puberty models, not cancer. It also activates steroid hormone biosynthesis [6, 12], the process by which hormones like estrogen are made, though this research was done in Leydig cells. For hormone-sensitive breast cancers, influencing this pathway is a significant consideration. These findings are from non-cancer studies, so their direct effect in breast cancer is unclear, but they warrant caution.
Bergamot: A Mixed Message
Bergamot, often used in Earl Grey tea, contains carvacrol. Some studies show it inhibits colorectal cancer and signal transduction [7, 8]. However, one study specifically in breast cancer cells found carvacrol promotes cell cycle arrest and apoptosis through the PI3K/AKT pathway [8]. This suggests a complex interaction that needs more research before it can be considered clearly beneficial or harmful alongside trastuzumab.
Molecular Pathway
Navigating Your Diet During Treatment
The relationship between food, supplements, and cancer drugs is intricate. Trastuzumab is metabolized by the body, and compounds that affect key enzyme systems could theoretically alter how your body processes the drug, impacting its effectiveness.
This article is based on laboratory and animal research. It is designed to inform you about potential interactions so you can have a detailed conversation with your oncology team. Always discuss any major dietary changes or new supplements with your doctor and a registered oncology dietitian. They can help you build a nutrition plan that supports your health and works in harmony with your treatment.
Want recommendations personalized to your exact diagnosis?
addon scores every food and supplement against your specific cancer type, treatment regimen, and genetic mutations - backed by the same evidence you see in this article.
Get your free preview